Resumen de acción MDT
Medtronic plc desarrolla, fabrica y vende terapias médicas basadas en dispositivos a sistemas sanitarios, médicos, clínicos y pacientes de todo el mundo.
| Puntuación del snowflake | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 1/6 |
| Rendimiento pasado | 3/6 |
| Salud financiera | 3/6 |
| Dividendos | 4/6 |
Recompensas
Análisis de riesgos
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Competidores de Medtronic plc
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$88.30 |
| Máximo en las últimas 52 semanas | US$92.68 |
| Mínimo de 52 semanas | US$72.08 |
| Beta | 0.85 |
| 1Cambio en 1 mes | -1.19% |
| Variación en 3 meses | 8.03% |
| Cambio de 1 año | 21.64% |
| 3Variación en 3 años | -25.16% |
| Variación en 5 años | -20.50% |
| Variación desde la OPV | 60,584.37% |
Noticias y actualizaciones recientes
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns
Nov 08
Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Oct 31Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?
Oct 13Recent updates
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns
Nov 08Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Oct 31Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?
Oct 13Medtronic: Undervalued Dividend Aristocrat With High Margins
Oct 10An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued
Sep 30Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks
Sep 16Medtronic: An Undervalued Stock With Durable Competitive Advantages
Sep 16Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Sep 05Medtronic: Is The Company Back?
Aug 26Medtronic: Still A Buy Before Earnings
Aug 17Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?
Jul 11Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year
Jun 27Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
Jun 10Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic's (NYSE:MDT) Dividend Will Be $0.69
Dec 12Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Medtronic: The Tide Is Turning
Aug 24Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Aug 21Rentabilidad de los accionistas
| MDT | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | -1.5% | 1.2% | 3.9% |
| 1Y | 21.6% | 27.0% | 33.2% |
Rentabilidad vs. Industria: Los resultados de MDT fueron inferiores a los de la industria US Medical Equipment, que obtuvo un rendimiento del 27% el año pasado.
Rentabilidad vs. Mercado: MDT obtuvo unos resultados inferiores a los del mercado US, que fueron del 33.2% el año pasado.
Volatilidad de los precios
| MDT volatility | |
|---|---|
| MDT Average Weekly Movement | 2.3% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: MDT no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de MDT (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1949 | 95,000 | Geoff Martha | www.medtronic.com |
Medtronic plc desarrolla, fabrica y vende terapias médicas basadas en dispositivos a sistemas sanitarios, médicos, clínicos y pacientes de todo el mundo. El segmento de la cartera cardiovascular ofrece marcapasos cardiacos implantables, desfibriladores cardioversores y dispositivos de terapia de resincronización cardiaca; productos de ablación cardiaca; sistemas de monitorización cardiaca insertables; productos TYRX; y software de monitorización remota y centrado en el paciente. También ofrece válvulas aórticas, productos de sustitución y reparación de válvulas quirúrgicas, endoprótesis endovasculares y accesorios, y válvulas pulmonares transcatéter; y productos de intervención coronaria percutánea, balones de angioplastia percutánea y otros productos.
Resumen de fundamentos de Medtronic plc
| Estadísticas fundamentales de MDT | |
|---|---|
| Capitalización bursátil | US$113.20b |
| Beneficios(TTM) | US$3.93b |
| Ingresos (TTM) | US$32.58b |
28.8x
Ratio precio-beneficio (PE)3.5x
Ratio precio-ventas (PS)¿Está MDT sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MDT | |
|---|---|
| Ingresos | US$32.58b |
| Coste de los ingresos | US$11.23b |
| Beneficio bruto | US$21.35b |
| Otros gastos | US$17.42b |
| Beneficios | US$3.93b |
Últimos beneficios comunicados
Jul 26, 2024
Próxima fecha de beneficios
Nov 19, 2024
| Beneficios por acción (BPA) | 3.06 |
| Margen bruto | 65.52% |
| Margen de beneficio neto | 12.05% |
| Ratio deuda/patrimonio | 57.8% |
¿Cómo se ha desempeñado MDT a largo plazo?
Ver rendimiento histórico y comparativa